User talk:PRUpdates

Your submission at Articles for creation: Sumitomo Pharma America, Inc. (SMPA) (July 10)
 Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by Karnataka was:

The comment the reviewer left was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Sumitomo Pharma America, Inc. (SMPA) and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:Sumitomo_Pharma_America,_Inc._(SMPA) Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:Karnataka&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Sumitomo_Pharma_America,_Inc._(SMPA) reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

Karnataka (talk) 16:32, 10 July 2023 (UTC)

Your submission at Articles for creation: Sumitomo Pharma America, Inc. (SMPA) (July 10)
 Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by DaxServer was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Sumitomo Pharma America, Inc. (SMPA) and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:Sumitomo_Pharma_America,_Inc._(SMPA) Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:DaxServer&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Sumitomo_Pharma_America,_Inc._(SMPA) reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

— DaxServer (t · m · e · c) 17:54, 10 July 2023 (UTC)

Your submission at Articles for creation: Sumitomo Pharma America, Inc. (July 11)
 Your recent article submission to Articles for Creation has been reviewed. Unfortunately, it has not been accepted at this time. The reason left by KylieTastic was:

Please check the submission for any additional comments left by the reviewer. You are encouraged to edit the submission to address the issues raised and resubmit after they have been resolved.


 * If you would like to continue working on the submission, go to Draft:Sumitomo Pharma America, Inc. and click on the "Edit" tab at the top of the window.
 * If you do not edit your draft in the next 6 months, it will be considered abandoned and may be deleted.
 * If you need any assistance, or have experienced any untoward behavior associated with this submission, you can ask for help at the [//en.wikipedia.org/w/index.php?title=Wikipedia:WikiProject_Articles_for_creation/Help_desk/New_question&withJS=MediaWiki:AFCHD-wizard.js&page=Draft:Sumitomo_Pharma_America,_Inc. Articles for creation help desk], on the [//en.wikipedia.org/w/index.php?title=User_talk:KylieTastic&action=edit&section=new&nosummary=1&preload=Template:AfC_decline/HD_preload&preloadparams%5B%5D=Draft:Sumitomo_Pharma_America,_Inc. reviewer's talk page] or use Wikipedia's real-time chat help from experienced editors.

KylieTastic (talk) 18:35, 11 July 2023 (UTC)

Managing a conflict of interest
Hello, PRUpdates. We welcome your contributions, but if you have an external relationship with the people, places or things you have written about on the page Draft:Sumitomo Pharma America, Inc., you may have a conflict of interest (COI). Editors with a conflict of interest may be unduly influenced by their connection to the topic. See the conflict of interest guideline and FAQ for organizations for more information. We ask that you:


 * avoid editing or creating articles about yourself, your family, friends, colleagues, company, organization, clients, or competitors;
 * propose changes on the talk pages of affected articles (you can use the Edit COI template);
 * disclose your conflict of interest when discussing affected articles (see Conflict of interest);
 * avoid linking to your organization's website in other articles (see Spam);
 * do your best to comply with Wikipedia's content policies.

In addition, you are required by the Wikimedia Foundation's terms of use to disclose your employer, client, and affiliation with respect to any contribution which forms all or part of work for which you receive, or expect to receive, compensation. See Paid-contribution disclosure.

Also, editing for the purpose of advertising, publicising, or promoting anyone or anything is not permitted. Thank you. KylieTastic (talk) 18:35, 11 July 2023 (UTC)


 * Paid Contribution Disclosure on User page PRUpdates (talk) 00:11, 14 July 2023 (UTC)

Nomination of Sumitomo Pharma America, Inc. for deletion
A discussion is taking place as to whether the article Sumitomo Pharma America, Inc. is suitable for inclusion in Wikipedia according to Wikipedia's policies and guidelines or whether it should be deleted.

The article will be discussed at Articles for deletion/Sumitomo Pharma America, Inc. until a consensus is reached, and anyone, including you, is welcome to contribute to the discussion. The nomination will explain the policies and guidelines which are of concern. The discussion focuses on high-quality evidence and our policies and guidelines.

Users may edit the article during the discussion, including to improve the article to address concerns raised in the discussion. However, do not remove the article-for-deletion notice from the top of the article until the discussion has finished. Star  Mississippi  21:00, 14 December 2023 (UTC)

Orphaned non-free image File:World Kinect.png
Thanks for uploading File:World Kinect.png. The image description page currently specifies that the image is non-free and may only be used on Wikipedia under a claim of fair use. However, the image is currently not used in any articles on Wikipedia. If the image was previously in an article, please go to the article and see why it was removed. You may add it back if you think that that will be useful. However, please note that images for which a replacement could be created are not acceptable for use on Wikipedia (see our policy for non-free media).

Note that any non-free images not used in any articles will be deleted after seven days, as described in section F5 of the criteria for speedy deletion. Thank you. --B-bot (talk) 02:45, 16 April 2024 (UTC)